AprilLMcVeyMD
Neurology • Kansas City, KSNeuromuscular Medicine, Neurophysiology
Professor, Neurology, University Kansas School of Medicine
Are you Dr. McVey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
4070 Delp Mail Stop 4017
Kansas City, KS 66160Phone+1 913-588-6970
Summary
- Dr. April McVey, MD is a board certified neurologist in Kansas City, Kansas. She is currently licensed to practice medicine in Kansas, Washington, and Texas. She is affiliated with St. Clare Hospital and is a Professor at University Kansas School of Medicine.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumResidency, Neurology, 1984 - 1985- San Antonio Uniformed Services Health Education ConsortiumResidency, Neurology, 1981 - 1983
- San Antonio Uniformed Services Health Education ConsortiumInternship, Internal Medicine, 1979 - 1980
Baylor College of MedicineClass of 1979
Certifications & Licensure
WA State Medical License 1999 - 2022
KS State Medical License 2001 - 2016
TX State Medical License 1979 - 2002- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 65 citationsAssociation Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.Jeri W. Nieves, Chris Gennings, Pam Factor-Litvak, Jonathan Hupf, Jessica Singleton
JAMA Neurology. 2016-12-01 - 117 citationsLong-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, Greg Minisman, Hui-Chien Kuo
The Lancet. Neurology. 2019-03-01 - 20 citationsConsistent improvement with eculizumab across muscle groups in myasthenia gravisRenato Mantegazza, Fanny O'Brien, Marcus Yountz, James F. Howard, Claudio Mazia
Annals of Clinical and Translational Neurology. 2020-08-01
